Rocket Pharmaceuticals
RCKT
RCKT
34 hedge funds and large institutions have $32.1M invested in Rocket Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 34 → 34 (0)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
Holders
34
Holding in Top 10
–
Calls
$104K
Puts
$23K
Top Buyers
| 1 | +$3.39M | |
| 2 | +$2.61M | |
| 3 | +$2.55M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$944K |
Top Sellers
| 1 | -$3.15M | |
| 2 | -$932K | |
| 3 | -$495K | |
| 4 |
SAM
Senzar Asset Management
New York
|
-$378K |
| 5 |
Millennium Management
New York
|
-$359K |